Seeking Alpha

ELN
Elan Corporation, plc

5/27/2012, 7:55 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ELN Market Currents more »
  • Friday 12:49 PM Elan (ELN +7.6%) shares see notable strength following positive comments on the potential of the company's Alzheimer's drug Bapineuzumab: The FDA is signalling "they will be very reasonable about getting something to patients that has a modicum of benefit," Chairman Robert Ingram says. Also goosing shares is mention of ELN as a takeover target: "If an offer comes, we can't ignore it..."
    Comment!
    [Healthcare, On the Move]
ELN in Focus more »
ELN Latest Transcript more »
Earlier ELN transcripts
ELN Instablog posts more »
  • Michael Price - MFP Investors Q4/2011 Fund Portfolio
    Sat, Feb 18 • Dividend Sheet • Comment!
  • 4 Names to Watch in a Tough Market
    Tue, Dec 27, 2011 • Kate Stalter • Comment!
  • Michael Price - MFP Investors Q3-2011 Fund Portfolio
    Tue, Dec 6, 2011 • Dividend Sheet • Comment!
  • A Few Breakout Candidates Emerge
    Thu, Oct 13, 2011 • Jeff Pierce • Comment!
  • Michael F. Price - MFP Investors Q2-2011 Fund Portfolio
    Thu, Aug 18, 2011 • Dividend Sheet • Comment!
Write a post on ELN
ELN StockTalks
ELN vs. ETF Alternatives
Company Description

Elan Corporation, plc, an Irish public limited company, is a neuroscience-based biotechnology company, listed on the Irish and New York Stock Exchanges, and headquartered in Dublin, Ireland. We were incorporated as a private limited company in Ireland in December 1969 and became a public limited... More